Papillary and Medullary Thyroid Carcinomas Presenting as Collision Tumors: A Case Series of 21 Cases at a Tertiary Care Cancer Center.


Journal

Head and neck pathology
ISSN: 1936-0568
Titre abrégé: Head Neck Pathol
Pays: United States
ID NLM: 101304010

Informations de publication

Date de publication:
Dec 2021
Historique:
received: 22 02 2021
accepted: 26 03 2021
pubmed: 12 4 2021
medline: 23 3 2022
entrez: 11 4 2021
Statut: ppublish

Résumé

Collision tumor is the occurrence of two histologically and morphologically distinct tumors within the same organ with no histological admixture. Collision tumors of the thyroid are extremely rare constituting < 1% of all thyroid tumors. Clinical profiles and pathological features of Medullary thyroid carcinoma (MTC) and Papillary thyroid carcinoma (PTC) presenting as Collision tumors of thyroid, diagnosed between 2009 and 2019, at a tertiary care cancer center were retrospectively analyzed. Collision tumors comprised 4.7% of all MTC cases diagnosed over 10 years. A total of 21 cases (11males, 11 females, M:F = 1) were retrieved with the mean age of patients being 45.33 years (range 26-77 years). More than half of PTCs involved the right lobe of the thyroid (66.6%). About half (53.4%) of MTCs affected the left lobe. Imaging done pre-operatively failed to identify the smaller second tumor in 60% of the cases with both tumours in separate lobes. Pre-operative FNAC showed only MTC in all 8 cases in which it was done. Papillary microcarcinoma (m-PTC) was seen in 85.7% cases, with one case of multifocal m-PTC. MTC (mean size 3.12 cm), on an average, was 3 times larger than the PTC (mean size 0.91 cm). The histological variants of MTC included-oncocytic (1/21, 4.7%), spindle cell (1/21, 4.7%), epithelial (3/21, 14.2%) and classical (16/21, 76.2%) and of PTC included classic PTC (12/21, 57.14%), Hurthle cell (2/21, 9.52%), tall cell (1/21, 4.76%) and follicular variant of PTC (6/21, 28.57%). The microscopic extrathyroidal extension (ETE) due to MTC and PTC component was 42.8% and 9.5% respectively. Lymph node metastasis was seen in 16 (76.2%) cases; 87.5% (14/16) of which were contributed by MTC, 12.5% (2/16) by PTC alone, and 12.5% (2/16) cases showed metastasis from both MTC and PTC. MTC had a higher stage than PTC in 85.5% of cases. Collision tumors of the thyroid are exceedingly rare, and possibly underdiagnosed due to variation in sampling techniques, especially of the grossly "normal lobe". The low incidence in our cohort is in favor of the "Chance theory" of co-occurrence. This diagnosis is important due to its therapeutic and prognostic implications.

Identifiants

pubmed: 33840044
doi: 10.1007/s12105-021-01323-7
pii: 10.1007/s12105-021-01323-7
pmc: PMC8633268
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1137-1146

Informations de copyright

© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Références

Endocr Pathol. 2003 Fall;14(3):269-76
pubmed: 14586073
Surgery. 1989 Jun;105(6):804-7
pubmed: 2727903
Curr Oncol. 2019 Oct;26(5):338-344
pubmed: 31708652
Am J Clin Pathol. 2015 Nov;144(5):811-6
pubmed: 26486747
J Clin Endocrinol Metab. 1990 Apr;70(4):826-9
pubmed: 2180977
CA Cancer J Clin. 2017 Mar;67(2):93-99
pubmed: 28094848
World J Surg Oncol. 2006 Sep 19;4:65
pubmed: 16984659
Thyroid. 2004 Nov;14(11):946-52
pubmed: 15671773
Am J Surg Pathol. 1996 Feb;20(2):245-50
pubmed: 8554115
Clin Endocrinol (Oxf). 2010 Feb;72(2):256-63
pubmed: 20447064
Virchows Arch. 1994;424(4):441-7
pubmed: 8205357
Acta Med Scand. 1981;209(5):421-4
pubmed: 7246276
Pathol Int. 2018 May;68(5):313-317
pubmed: 29575341
Cancer. 2006 Sep 15;107(6):1255-64
pubmed: 16900519
Tumori. 1997 May-Jun;83(3):653-5
pubmed: 9267482
JAMA Oncol. 2016 Aug 1;2(8):1023-9
pubmed: 27078145
J Lab Physicians. 2014 Jul;6(2):133-5
pubmed: 25328343
J Cancer Res Ther. 2014 Jul-Sep;10(3):693-5
pubmed: 25313762
Endocr Relat Cancer. 2005 Jun;12(2):281-9
pubmed: 15947103
Am J Ther. 2014 Nov-Dec;21(6):e234-8
pubmed: 23689091
Surg Today. 1993;23(1):9-12
pubmed: 8461613
Hum Pathol. 1989 Jan;20(1):83-6
pubmed: 2912879
Int J Gynecol Pathol. 2017 May;36(3):261-264
pubmed: 27513075
Head Neck. 2015 Oct;37(10):E125-9
pubmed: 25491252
Abdom Radiol (NY). 2017 Dec;42(12):2909-2926
pubmed: 28623377
J Clin Diagn Res. 2016 Jun;10(6):PD03-4
pubmed: 27504346
Semin Oncol. 1987 Sep;14(3):306-14
pubmed: 2888195
Head Neck. 2004 Jul;26(7):637-41
pubmed: 15229907
Cancer Med. 2019 Oct;8(13):6151-6161
pubmed: 31408923
Thyroid. 2016 Jan;26(1):1-133
pubmed: 26462967
Thyroid. 2015 Jun;25(6):567-610
pubmed: 25810047
Eur Arch Otorhinolaryngol. 2002 Apr;259(4):217-21
pubmed: 12064511
Thyroid. 2002 Jul;12(7):557-61
pubmed: 12193298

Auteurs

Ann Thomas (A)

Department of Pathology, Tata Memorial Hospital, Parel, Mumbai, Maharashtra, 400012, India.
Homi Bhabha National Institute, Mumbai, 400012, India.

Neha Mittal (N)

Department of Pathology, Tata Memorial Hospital, Parel, Mumbai, Maharashtra, 400012, India. drmittalneha@gmail.com.
Homi Bhabha National Institute, Mumbai, 400012, India. drmittalneha@gmail.com.

Swapnil U Rane (SU)

Homi Bhabha National Institute, Mumbai, 400012, India.
Department of Pathology, Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Mumbai, India.

Munita Bal (M)

Department of Pathology, Tata Memorial Hospital, Parel, Mumbai, Maharashtra, 400012, India.
Homi Bhabha National Institute, Mumbai, 400012, India.

Asawari Patil (A)

Homi Bhabha National Institute, Mumbai, 400012, India.
Department of Pathology, Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Mumbai, India.

Suman Kumar Ankathi (SK)

Homi Bhabha National Institute, Mumbai, 400012, India.
Department of Radiology, Tata Memorial Hospital, Parel, Mumbai, Maharashtra, 400012, India.

Richa Vaish (R)

Homi Bhabha National Institute, Mumbai, 400012, India.
Department of Head and Neck Surgical Oncology, Tata Memorial Hospital, Parel, Mumbai, Maharashtra, 400012, India.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH